Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10886084 | Drug Discovery Today | 2015 | 6 Pages |
Abstract
- Intracellular agent targets mutant proteins and induces apoptosis.
- Chimera with a targeting domain, a molecular switch and a pro-apoptotic effector.
- A constitutively active caspase-3 mutant (V266E), efficient at low concentrations.
- Engineered mAb or zinc finger targeting tumor-specific mutations.
- Inteins provide flexible platform for control of protein function.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Scott Tarone,